US Supreme Court Sides With Thermo Fisher In Diagnostics Patent Spat
Executive Summary
The justices struck down an appeals court ruling that a single device component could count as a “substantial portion” under patent infringement laws.
You may also be interested in...
US Urges High Court To Take Patent Case Claiming Overseas Inducement
The case between Promega and Life Tech turns on whether a company violates US patent law by shipping a single allegedly patented component overseas for assembly. The Solicitor General’s office says it does not, arguing that the Federal Circuit’s reading would expose US manufacturers to too much risk of patent liability.
Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs
A proposed rule from the US Food and Drug Administration would allow the agency to take on regulation of lab-developed tests by phasing out the previous approach of enforcement discretion
OMB Clears Proposed Rule On Lab-Developed Tests
The US FDA appears poised to release long-promised regulations on lab-developed tests. However, some industry observers still have doubts as to whether the agency is truly prepared.